X

Xenon Pharmaceuticals
D

XENE

41.190
USD
1.36
(3.41%)
Market Closed
Volume
7,220
EPS
-3
Div Yield
-
P/E
-15
Market Cap
3,140,309,206
OverviewSignalsIdeasNews
Related Instruments
    ALNY
    ALNY
    -22.650
    (-8.77%)
    235.480 USD
    BIIB
    BIIB
    -4.840
    (-2.94%)
    160.000 USD
    B
    BLUE
    -0.04270
    (-11.74%)
    0.32090 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    N
    NBIX
    -5.465
    (-4.45%)
    117.410 USD
    R
    RARE
    -2.865
    (-6.02%)
    44.745 USD
    S
    SGEN
    0
    (0%)
    0.000000 USD
    S
    SRPT
    -4.470
    (-4.10%)
    104.600 USD
    VRTX
    VRTX
    -18.53
    (-3.83%)
    450.72 USD
    X
    XNCR
    -0.420
    (-1.79%)
    23.090 USD
    More
News

Title: Xenon Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.